Subtopic Deep Dive

Aldo-Keto Reductase Superfamily in Oxidative Stress
Research Guide

What is Aldo-Keto Reductase Superfamily in Oxidative Stress?

The aldo-keto reductase (AKR) superfamily comprises NADPH-dependent enzymes that detoxify reactive carbonyls and aldehydes produced during oxidative stress in mammalian cells.

AKR enzymes, including aldose reductase (AKR1B1), reduce lipid peroxidation products like 4-hydroxynonenal to less toxic alcohols. Over 100 papers document their roles in diabetes, cancer, and inflammation. Srivastava et al. (2005) received 518 citations linking AKR1B1 to diabetic complications via polyol pathway activation.

Curated Papers

Key Challenges

Why It Matters

AKR enzymes protect against oxidative damage in diabetes, where Srivastava, Ramana, and Bhatnagar (2005) showed aldose reductase detoxifies aldehydes from hyperglycemia-induced lipid peroxidation, suggesting AR inhibitors as therapies. In vasculitis, Rittner et al. (1999, 206 citations) demonstrated aldose reductase reduces lipid peroxidation products, preventing vascular inflammation. Cancer studies by Fukumoto et al. (2005, 290 citations) correlated AKR1B10 overexpression with smokers' lung carcinomas, indicating prognostic value. AKR1C3 activates prodrugs like PR-104A under aerobic conditions (Guise et al., 2010, 184 citations), advancing targeted chemotherapy.

Key Research Challenges

Substrate Specificity Variation

AKR isoforms like AKR1B1 and AKR1B10 show differing affinities for carbonyls from lipid peroxidation. Singh, Kapoor, and Bhatnagar (2015) detailed oxidative and reductive metabolism of these carbonyls. This variability complicates therapeutic targeting across diseases.

Dual Protective-Pathogenic Roles

AKRs detoxify harmful aldehydes but exacerbate diabetic complications via polyol pathway. Srivastava, Ramana, and Bhatnagar (2005, 518 citations) highlighted this in diabetes oxidative damage. Balancing inhibition remains challenging.

Inflammatory Context Modulation

Oxidative stress upregulates AKRs in vasculitis and cancer, but mechanisms differ. Rittner et al. (1999, 206 citations) showed detoxification in vasculitis; Fukumoto et al. (2005) linked AKR1B10 to lung cancer. Predictive modeling of expression is limited.

Essential Papers

Role of Aldose Reductase and Oxidative Damage in Diabetes and the Consequent Potential for Therapeutic Options

Satish K. Srivastava, Kota V. Ramana, Aruni Bhatnagar · 2005 · Endocrine Reviews · 518 citations

Aldose reductase (AR) is widely expressed aldehyde-metabolizing enzyme. The reduction of glucose by the AR-catalyzed polyol pathway has been linked to the development of secondary diabetic complica...

Overexpression of the Aldo-Keto Reductase Family Protein AKR1B10 Is Highly Correlated with Smokers' Non–Small Cell Lung Carcinomas

Shinichi Fukumoto, Naoko Yamauchi, Hisashi Moriguchi et al. · 2005 · Clinical Cancer Research · 290 citations

Abstract Purpose: Squamous cell carcinoma (SCC) and adenocarcinoma of the lung are currently subject to similar treatment regimens despite distinct differences in histology and epidemiology. The ai...

Fundamental roles of reactive oxygen species and protective mechanisms in the female reproductive system

Junichi Fujii, Yoshihito Iuchi, Futoshi Okada · 2005 · Reproductive Biology and Endocrinology · 286 citations

Abstract Controlled oxidation, such as disulfide bond formation in sperm nuclei and during ovulation, plays a fundamental role in mammalian reproduction. Excess oxidation, however, causes oxidative...

Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis

Heike L. Rittner, Verena Häfner, Piotr Adrian Klimiuk et al. · 1999 · Journal of Clinical Investigation · 206 citations

Giant cell arteritis (GCA) is a systemic vasculitis preferentially affecting large and medium-sized arteries. Inflammatory infiltrates in the arterial wall induce luminal occlusion with subsequent ...

The Bioreductive Prodrug PR-104A Is Activated under Aerobic Conditions by Human Aldo-Keto Reductase 1C3

Christopher P. Guise, Maria R. Abbattista, Rachelle S. Singleton et al. · 2010 · Cancer Research · 184 citations

Abstract PR-104, currently in phase II clinical trials, is a phosphate ester pre-prodrug which is converted in vivo to its cognate alcohol, PR-104A, a prodrug designed to exploit tumor hypoxia. Bio...

NADPH-dependent Reductases Involved in the Detoxification of Reactive Carbonyls in Plants

Yasuo Yamauchi, Ayaka Hasegawa, Ai Taninaka et al. · 2010 · Journal of Biological Chemistry · 174 citations

Reactive carbonyls, especially α,β-unsaturated carbonyls produced through lipid peroxidation, damage biomolecules such as proteins and nucleotides; elimination of these carbonyls is therefore essen...

Insights into Aldehyde Dehydrogenase Enzymes: A Structural Perspective

Kim Shortall, Ahmed Djeghader, Edmond Magner et al. · 2021 · Frontiers in Molecular Biosciences · 170 citations

Aldehyde dehydrogenases engage in many cellular functions, however their dysfunction resulting in accumulation of their substrates can be cytotoxic. ALDHs are responsible for the NAD(P)-dependent o...

Reading Guide

Foundational Papers

Start with Srivastava, Ramana, Bhatnagar (2005, 518 citations) for AR in diabetic oxidative damage; Rittner et al. (1999, 206 citations) for lipid peroxidation detoxification in vasculitis. These establish core protective mechanisms.

Recent Advances

Study Singh, Kapoor, Bhatnagar (2015) on carbonyl metabolism; Guise et al. (2010, 184 citations) on AKR1C3 prodrug activation. These advance therapeutic applications.

Core Methods

NADPH-reduction assays for kinetics; qPCR/Western blots for expression (Fukumoto 2005); LC-MS for carbonyl substrates (Yamauchi 2010); structural modeling of active sites.

How PapersFlow Helps You Research Aldo-Keto Reductase Superfamily in Oxidative Stress

Discover & Search

Research Agent uses searchPapers('aldo-keto reductase oxidative stress') to retrieve Srivastava et al. (2005) and citationGraph to map 518-citation connections to Rittner et al. (1999). exaSearch uncovers plant homologs like Yamauchi et al. (2010); findSimilarPapers expands to AKR1C3 prodrug activation (Guise et al., 2010).

Analyze & Verify

Analysis Agent applies readPaperContent on Srivastava et al. (2005) to extract polyol pathway kinetics, then verifyResponse with CoVe checks claims against Bhatnagar co-authors. runPythonAnalysis simulates NADPH reduction rates using NumPy on lipid peroxidation data from Singh et al. (2015); GRADE scores evidence strength for therapeutic claims.

Synthesize & Write

Synthesis Agent detects gaps in AKR isoform specificity between diabetes (Srivastava 2005) and cancer (Fukumoto 2005), flags contradictions in protective roles. Writing Agent uses latexEditText for structural models, latexSyncCitations for Srivastava bibliography, latexCompile for publication-ready reviews; exportMermaid diagrams AKR detoxification pathways.

Use Cases

"Analyze kinetic data from AKR1B1 in Srivastava 2005 for Python simulation of aldehyde reduction rates."

Research Agent → searchPapers → Analysis Agent → readPaperContent(Srivastava 2005) → runPythonAnalysis(NumPy plot Km/Vmax for glucose vs. 4-HNE) → matplotlib graph of detoxification efficiency.

"Write LaTeX review on AKR roles in vasculitis oxidative stress citing Rittner 1999."

Synthesis Agent → gap detection → Writing Agent → latexEditText(structural pathway) → latexSyncCitations(Rittner 1999, Srivastava 2005) → latexCompile → PDF with embedded figures.

"Find code for modeling AKR1C3 prodrug activation from Guise 2010."

Research Agent → paperExtractUrls(Guise 2010) → paperFindGithubRepo → Code Discovery → githubRepoInspect → Python script for bioreductive kinetics under aerobic conditions.

Automated Workflows

Deep Research workflow scans 50+ AKR papers via searchPapers, structures report on oxidative stress roles with GRADE grading of Srivastava (2005) evidence. DeepScan applies 7-step analysis: citationGraph → readPaperContent(Fukumoto 2005) → CoVe verification → gap synthesis. Theorizer generates hypotheses on AKR1B10 inhibition from lung cancer data (Fukumoto 2005) to diabetes models (Srivastava 2005).

Try Doxa for Aldo-Keto Reductase Superfamily in Oxidative Stress Research

Frequently Asked Questions

What defines the aldo-keto reductase superfamily in oxidative stress?

NADPH-dependent enzymes reducing reactive carbonyls from lipid peroxidation, including AKR1B1 (aldose reductase) and AKR1B10, as foundational in Srivastava et al. (2005).

What methods study AKR functions?

Enzyme kinetics for substrate specificity (Singh et al., 2015), overexpression analysis in cancers (Fukumoto et al., 2005), and prodrug activation assays (Guise et al., 2010).

What are key papers?

Srivastava, Ramana, Bhatnagar (2005, 518 citations) on diabetes; Rittner et al. (1999, 206 citations) on vasculitis detoxification; Fukumoto et al. (2005, 290 citations) on lung cancer.

What open problems exist?

Isoform-specific inhibitors balancing detoxification vs. pathogenic polyol flux (Srivastava 2005); predicting AKR upregulation in inflammation (Rittner 1999); aerobic activation mechanisms (Guise 2010).